10 research outputs found

    Low levels of CD36 in peripheral blood monocytes in subclinical atherosclerosis in rheumatoid arthritis: A cross-sectional study in a mexican population

    No full text
    Patients with rheumatoid arthritis (RA) have a higher risk for atherosclerosis. There is no clinical information about scavenger receptor CD36 and the development of subclinical atherosclerosis in patients with RA. The aim of this study was to evaluate the association between membrane expression of CD36 in peripheral blood mononuclear cells (PBMC) and carotid intima-media thickness (cIMT) in patients with RA. Methods. We included 67 patients with RA from the Rheumatology Department of Hospital Civil "Dr. Juan I. Menchaca," Guadalajara, Jalisco, Mexico. We evaluated the cIMT, considering subclinical atherosclerosis when >0.6 mm. Since our main objective was to associate the membrane expression of CD36 with subclinical atherosclerosis, other molecules related with cardiovascular risk such as ox-LDL, IL-6, and TNF ? were tested. Results. We found low CD36 membrane expression in PBMC from RA patients with subclinical atherosclerosis (P < 0.001). CD36 mean fluorescence intensity had negative correlations with cIMT (r = -0.578, P < 0.001), ox-LDL (r = -0.427, P = 0.05), TNF ? (r = -0.729, P < 0.001), and IL-6 (r = -0.822, P < 0.001). Conclusion. RA patients with subclinical atherosclerosis showed low membrane expression of CD36 in PBMC and increased serum proinflammatory cytokines. Further studies are needed to clarify the regulation of CD36 in RA. � 2014 Eduardo G�mez-Ba�uelos et al

    Dengue

    No full text
    Lecture 49 ISBN e-book : 9781615045754International audienc

    Asymptotic behavior of a scalar field with an arbitrary potential trapped on a Randall-Sundrum’s braneworld: the effect of a negative dark radiation term on a Bianchi I brane

    No full text

    Drugs in Development

    No full text

    Dengue

    No full text
    corecore